查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1955105

生物淨化市場：市場規模、佔有率、成長率、產業分析、按類型、應用和地區分類的分析以及未來預測（2026-2034 年）

Bio-Decontamination Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 143 Pages | 商品交期: 請詢問到貨日

價格

生物淨化市場成長要素

隨著各行各業和醫療機構日益重視消除有害微生物以預防感染和污染，全球生物淨化市場正穩定成長。根據 Fortune Business Insights 預測，該市場規模預計將在 2025 年達到 2.199 億美元，並在 2026 年成長至 2.286 億美元。到 2034 年，市場規模預計將達到 3.293 億美元，在 2026 年至 2034 年的預測期內，複合年成長率 (CAGR) 為 4.70%。

市場概況及成長要素

生物淨化是醫療機構、製藥生產和醫療設備製造中的關鍵製程。它採用物理和化學方法去除有害微生物，確保無菌環境。生物淨化解決方案的日益普及主要受住院率、外科手術量以及醫院感染（HAI）流行率上升的推動。預計到2025年，北美將以34.60%的市場佔有率引領市場，這主要得益於嚴格的感染控制法規以及對醫療淨化工藝投入的增加。

製藥和醫療設備製造商、研究機構和醫院正在大力投資生物淨化系統，以確保最終產品的無菌性。在嚴格的法規結構下，新藥和醫療設備的上市受到越來越多的關注，這進一步推動了這項需求。例如，美國FDA在2023年核准了53種新藥，高於2022年的37種，這迫使製造商實施先進的淨化程序以滿足安全標準。

新冠疫情對市場的影響

新冠疫情加速了生物消毒產品的普及應用。醫療和製藥業對滅菌和消毒需求的激增凸顯了高效消毒解決方案的重要性。例如，TOMI Environmental Solutions, Inc.等公司2020年的營收較2019年成長了249.3%，反映了市場需求的激增。疫情過後，隨著產品使用恢復正常，市場成長趨於穩定，TOMI在2022年實現了7.5%的年成長。

市場趨勢和技術整合

市場參與者正在加速整合先進技術以提高效率。例如，2023年9月，Telstar推出了一款配備離子化過氧化氫（ionHP+）系統的安全氣鎖系統（SAS）。該系統能夠將生物污染負荷降低六個數量級（log 6），同時最大限度地減少材料劣化。此類技術創新滿足了無菌製藥生產和研究環境的需求，並持續推動市場成長。

細分市場分析

  • 產品細分：受監管要求、技術進步以及對自動化消毒系統日益成長的需求的推動，設備將主導市場，到 2026 年將佔 80.23%（1.834 億美元）的佔有率。隨著醫療和製藥行業應用範圍的擴大，耗材預計將穩定成長。
  • 按類型分類：受製藥生產和研發中物料轉移需求的推動，預計到 2026 年，艙室消毒將佔市場佔有率的 55.03%（1.258 億美元）。艙室消毒方法的應用正在不斷擴大，以減少院內感染和手術部位感染。
  • 按消毒劑種類分類：過氧化氫因其安全性和有效性而成為領先的消毒劑，預計到 2026 年將佔市場佔有率的 62.82%（1.436 億美元）。二氧化氯是第二大消毒劑，這得益於其在滅菌應用方面獲得的監管核准不斷增加。
  • 按最終用戶分類：在嚴格的產品安全準則的支持下，製藥和醫療設備製造商預計將在 2026 年佔 63.47% 的市場佔有率（1.451 億美元）。醫院、醫療機構和研究機構也是重要的採用者，這主要得益於外科手術量的增加和感染預防需求的成長。

區域洞察

截至2025年，北美將以7,602萬美元的市場規模引領市場，主要促進因素為高住院率、外科手術以及消毒技術的應用。歐洲緊追在後，預計到2026年，英國和德國的市場規模將分別達到1,140萬美元和1,500萬美元。亞太地區預計將達到最高的複合年成長率，預計到2026年，中國將達到1,450萬美元，日本將達到1,880萬美元，印度將達到770萬美元。這主要得益於製藥業的擴張和感染控制意識的提高。

主要企業及策略趨勢

市場呈現半集中式格局，主要參與者包括STERIS（美國）、Bioquell（英國）、TOMI Environmental Solutions, Inc.（美國）和Amira Srl Unipersonale（義大利）。每家公司都專注於策略聯盟、產品推出以及併購，以拓展業務。關鍵進展包括STERIS於2021年推出新一代過氧化氫蒸氣系統，以及TOMI於2023年與Cellares合作，將iHP技術整合到細胞療法生產流程中。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章 主要考慮因素

  • 生物淨化產品的技術進步
  • 產業重大發展：合併、聯盟與收購。
  • 新產品發布
  • 新冠疫情對生物淨化市場的影響

第5章：全球生物淨化市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：按產品分類
    • 裝置
    • 消耗品
  • 市場分析、洞察與預測：按藥物類型分類
    • 過氧化氫
    • 二氧化氯
    • 過氧乙酸
    • 二氧化氮
  • 市場分析、洞察與預測：按類型
    • 艙室消毒
    • 室內消毒
  • 市場分析、洞察與預測：按最終用戶分類
    • 製藥和醫療設備製造商
    • 製藥契約製造和開發組織
    • 醫院和醫療設施
    • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 其他地區（ROW）

第6章：北美生物淨化市場分析：洞察與預測（2021-2034）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲生物淨化市場分析：洞察與預測（2021-2034）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲國家

第8章：亞太生物淨化市場分析：洞察與預測（2021-2034）

  • 國家
    • 日本
    • 中國
    • 印度
    • 亞太其他地區

第9章：其他地區（ROW）生物淨化市場分析：探討與預測（2021-2034 年）

第10章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • STERIS
    • Bioquell（Ecolab）
    • JCE Biotechnology
    • Fedegari Autoclavi SpA
    • TOMI Environmental Solutions, Inc.
    • Amira Srl Unipersonale
    • Zhejiang Tailin Bioengineering Co., Ltd.
    • Noxilizer, Inc.
    • ChlorDisys Solutions Inc.
Product Code: FBI107160

Growth Factors of bio-decontamination Market

The global bio-decontamination market is witnessing steady growth as industries and healthcare facilities focus on eliminating harmful microorganisms to prevent infection and contamination. According to Fortune Business Insights, the market was valued at USD 219.9 million in 2025 and is projected to grow to USD 228.6 million in 2026. By 2034, the market is expected to reach USD 329.3 million, registering a CAGR of 4.70% during the forecast period from 2026 to 2034.

Market Overview and Growth Drivers

Bio-decontamination is a critical process in healthcare facilities, pharmaceutical production, and medical device manufacturing. It involves the use of physical and chemical methods to eliminate harmful microorganisms and ensure sterile conditions. The rising adoption of bio-decontamination solutions is largely fueled by the increasing number of hospital admissions, surgical procedures, and the prevalence of hospital-acquired infections (HAIs). North America dominated the market in 2025 with a 34.60% share, driven by stringent infection control regulations and growing investments in healthcare decontamination processes.

Pharmaceutical and medical device manufacturers, research organizations, and hospitals are investing significantly in bio-decontamination systems to ensure sterile end products. The growing focus on launching new drugs and medical devices under strict regulatory frameworks has further increased demand. For instance, the U.S. FDA approved 53 novel drugs in 2023, compared to 37 in 2022, compelling manufacturers to implement advanced decontamination procedures to meet safety standards.

COVID-19 Impact on the Market

The COVID-19 pandemic accelerated the adoption of bio-decontamination products. Increased demand for sterilization and disinfection in healthcare and pharmaceutical settings highlighted the importance of effective decontamination solutions. Companies such as TOMI Environmental Solutions, Inc. witnessed revenue growth of 249.3% in 2020 compared to 2019, reflecting the surge in demand. Post-pandemic, market growth stabilized, with TOMI reporting 7.5% growth in 2022 compared to 2021, as product utilization normalized.

Market Trends and Technological Integration

Market players are increasingly integrating advanced technologies to enhance efficiency. For example, Telstar introduced the Safety Airlock System (SAS) with its ionized Hydrogen Peroxide (ionHP+) system in September 2023, allowing a log 6 reduction in bioburden while minimizing material degradation. Such technological innovations continue to propel market growth, catering to aseptic pharmaceutical manufacturing and research environments.

Segment Analysis

  • By Product: Equipment dominates the market, accounting for 80.23% in 2026 with a value of USD 183.4 million, due to regulatory requirements, technological advancements, and the growing need for automated decontamination systems. Consumables are expected to grow steadily with increasing availability and adoption in healthcare and pharmaceutical sectors.
  • By Type: Chamber decontamination held a 55.03% share in 2026 (USD 125.8 million), driven by material transfer needs in drug manufacturing and research. Room decontamination methods are gaining traction to reduce hospital-acquired and surgical site infections.
  • By Agent: Hydrogen peroxide is the leading decontamination agent, representing 62.82% in 2026 (USD 143.6 million) due to its safety and effectiveness. Chlorine dioxide is the second-largest segment, benefiting from increasing regulatory approvals for sterilization use.
  • By End-user: Pharmaceutical & medical device manufacturers accounted for 63.47% of the market in 2026 (USD 145.1 million), supported by stringent guidelines for product safety. Hospitals, healthcare facilities, and research organizations are also significant adopters, driven by rising surgical procedures and infection prevention needs.

Regional Insights

North America led the market in 2025 with a value of USD 76.02 million, driven by high hospital admissions, surgical procedures, and adoption of decontamination practices. Europe follows, with the UK and Germany markets projected at USD 11.4 million and USD 15 million by 2026, respectively. Asia Pacific is expected to register the highest CAGR, with China at USD 14.5 million, Japan at USD 18.8 million, and India at USD 7.7 million by 2026, due to growing pharmaceutical manufacturing and infection control awareness.

Key Players and Strategic Developments

The market is semi-consolidated, with major players including STERIS (U.S.), Bioquell (U.K.), TOMI Environmental Solutions, Inc. (U.S.), and Amira Srl Unipersonale (Italy). Companies are focusing on strategic collaborations, product launches, and mergers & acquisitions to expand their footprint. Notable developments include STERIS launching next-generation vaporized hydrogen peroxide systems in 2021 and TOMI partnering with Cellares in 2023 to integrate iHP technology into cell therapy manufacturing.

Conclusion

The bio-decontamination market is poised for significant growth between 2025 and 2034, driven by increasing healthcare demands, regulatory pressures, and technological advancements. While product recalls and certain operational limitations may restrain growth, the rising focus on infection control, aseptic manufacturing, and research safety will continue to drive adoption across pharmaceutical, medical device, and healthcare sectors. North America will maintain its leadership, while Asia Pacific offers high-growth opportunities due to expanding manufacturing and heightened awareness regarding contamination prevention.

Segmentation By Product

  • Equipment
  • Consumables

By Type

  • Chamber Decontamination
  • Room Decontamination

By Agent

  • Hydrogen Peroxide
  • Chlorine Dioxide
  • Peracetic Acid
  • Nitrogen Dioxide

By End User

  • Pharmaceutical & Medical Device Manufacturers
  • Contract Manufacturing and Research Organizations
  • Hospital & Healthcare Facilities
  • Others

By Region

  • North America (By Product, Type, Agent, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Product, Type, Agent, End-user, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Product, Type, Agent, End-user, and Country/Sub-region)
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Rest of World (By Product, Type, Agent, and End-user)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in Bio-Decontamination Products
  • 4.2. Key Industry Developments: Mergers, Partnership, Acquisitions
  • 4.3. New Product Launches
  • 4.4. Impact of COVID-19 on Bio-Decontamination Market

5. Global Bio-Decontamination Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Equipment
    • 5.1.2. Consumables
  • 5.2. Market Analysis, Insights and Forecast - By Agent
    • 5.2.1. Hydrogen Peroxide
    • 5.2.2. Chlorine Dioxide
    • 5.2.3. Peracetic Acid
    • 5.2.4. Nitrogen Dioxide
  • 5.3. Market Analysis, Insights and Forecast - By Type
    • 5.3.1. Chamber Decontamination
    • 5.3.2. Room Decontamination
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Pharmaceutical & Medical Device Manufacturers
    • 5.4.2. Contract Manufacturing and Research Organizations
    • 5.4.3. Hospitals & Healthcare Facilities
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Rest of the World

6. North America Bio-Decontamination Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Equipment
    • 6.1.2. Consumables
  • 6.2. Market Analysis, Insights and Forecast - By Agent
    • 6.2.1. Hydrogen Peroxide
    • 6.2.2. Chlorine Dioxide
    • 6.2.3. Peracetic Acid
    • 6.2.4. Nitrogen Dioxide
  • 6.3. Market Analysis, Insights and Forecast - By Type
    • 6.3.1. Chamber Decontamination
    • 6.3.2. Room Decontamination
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Pharmaceutical & Medical Device Manufacturers
    • 6.4.2. Contract Manufacturing and Research Organizations
    • 6.4.3. Hospitals & Healthcare Facilities
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Bio-Decontamination Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Equipment
    • 7.1.2. Consumables
  • 7.2. Market Analysis, Insights and Forecast - By Agent
    • 7.2.1. Hydrogen Peroxide
    • 7.2.2. Chlorine Dioxide
    • 7.2.3. Peracetic Acid
    • 7.2.4. Nitrogen Dioxide
  • 7.3. Market Analysis, Insights and Forecast - By Type
    • 7.3.1. Chamber Decontamination
    • 7.3.2. Room Decontamination
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Pharmaceutical & Medical Device Manufacturers
    • 7.4.2. Contract Manufacturing and Research Organizations
    • 7.4.3. Hospitals & Healthcare Facilities
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Rest of Europe

8. Asia Pacific Bio-Decontamination Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Equipment
    • 8.1.2. Consumables
  • 8.2. Market Analysis, Insights and Forecast - By Agent
    • 8.2.1. Hydrogen Peroxide
    • 8.2.2. Chlorine Dioxide
    • 8.2.3. Peracetic Acid
    • 8.2.4. Nitrogen Dioxide
  • 8.3. Market Analysis, Insights and Forecast - By Type
    • 8.3.1. Chamber Decontamination
    • 8.3.2. Room Decontamination
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Pharmaceutical & Medical Device Manufacturers
    • 8.4.2. Contract Manufacturing and Research Organizations
    • 8.4.3. Hospitals & Healthcare Facilities
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Rest of Asia Pacific

9. Rest of the World Bio-Decontamination Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Equipment
    • 9.1.2. Consumables
  • 9.2. Market Analysis, Insights and Forecast - By Agent
    • 9.2.1. Hydrogen Peroxide
    • 9.2.2. Chlorine Dioxide
    • 9.2.3. Peracetic Acid
    • 9.2.4. Nitrogen Dioxide
  • 9.3. Market Analysis, Insights and Forecast - By Type
    • 9.3.1. Chamber Decontamination
    • 9.3.2. Room Decontamination
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Pharmaceutical & Medical Device Manufacturers
    • 9.4.2. Contract Manufacturing and Research Organizations
    • 9.4.3. Hospitals & Healthcare Facilities
    • 9.4.4. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. STERIS
      • 10.2.1.1. Overview
      • 10.2.1.2. Products
      • 10.2.1.3. SWOT analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. Financials (Based on Availability)
    • 10.2.2. Bioquell (Ecolab)
      • 10.2.2.1. Overview
      • 10.2.2.2. Products
      • 10.2.2.3. SWOT analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. Financials (Based on Availability)
    • 10.2.3. JCE Biotechnology
      • 10.2.3.1. Overview
      • 10.2.3.2. Products
      • 10.2.3.3. SWOT analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. Financials (Based on Availability)
    • 10.2.4. Fedegari Autoclavi S.p.A.
      • 10.2.4.1. Overview
      • 10.2.4.2. Products
      • 10.2.4.3. SWOT analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. Financials (Based on Availability)
    • 10.2.5. TOMI Environmental Solutions, Inc.
      • 10.2.5.1. Overview
      • 10.2.5.2. Products
      • 10.2.5.3. SWOT analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. Financials (Based on Availability)
    • 10.2.6. Amira Srl Unipersonale
      • 10.2.6.1. Overview
      • 10.2.6.2. Products
      • 10.2.6.3. SWOT analysis
      • 10.2.6.4. Recent Developments
      • 10.2.6.5. Strategies
      • 10.2.6.6. Financials (Based on Availability)
    • 10.2.7. Zhejiang Tailin Bioengineering Co., Ltd.
      • 10.2.7.1. Overview
      • 10.2.7.2. Products
      • 10.2.7.3. SWOT analysis
      • 10.2.7.4. Recent Developments
      • 10.2.7.5. Strategies
      • 10.2.7.6. Financials (Based on Availability)
    • 10.2.8. Noxilizer, Inc.
      • 10.2.8.1. Overview
      • 10.2.8.2. Products
      • 10.2.8.3. SWOT analysis
      • 10.2.8.4. Recent Developments
      • 10.2.8.5. Strategies
      • 10.2.8.6. Financials (Based on Availability)
    • 10.2.9. ChlorDisys Solutions Inc.
      • 10.2.9.1. Overview
      • 10.2.9.2. Products
      • 10.2.9.3. SWOT analysis
      • 10.2.9.4. Recent Developments
      • 10.2.9.5. Strategies
      • 10.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global Bio-Decontamination Market Revenue (USD million) Forecast, By Product, 2021-2034
  • Table 02: Global Bio-Decontamination Market Revenue (USD million) Forecast, By Agent, 2021-2034
  • Table 03: Global Bio-Decontamination Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 04: Global Bio-Decontamination Market Revenue (USD million) Forecast, By End User, 2021-2034
  • Table 05: Global Bio-Decontamination Market Revenue (USD million) Forecast, By Region, 2021-2034
  • Table 06: North America Bio-Decontamination Market Revenue (USD million) Forecast, By Product, 2021-2034
  • Table 07: North America Bio-Decontamination Market Revenue (USD million) Forecast, By Agent, 2021-2034
  • Table 08: North America Bio-Decontamination Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 09: North America Bio-Decontamination Market Revenue (USD million) Forecast, By End User, 2021-2034
  • Table 10: North America Bio-Decontamination Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 11: Europe Bio-Decontamination Market Revenue (USD million) Forecast, By Product, 2021-2034
  • Table 12: Europe Bio-Decontamination Market Revenue (USD million) Forecast, By Agent, 2021-2034
  • Table 13: Europe Bio-Decontamination Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 14: Europe Bio-Decontamination Market Revenue (USD million) Forecast, By End User, 2021-2034
  • Table 15: Europe Bio-Decontamination Market Revenue (USD million) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 16: Asia Pacific Bio-Decontamination Market Revenue (USD million) Forecast, By Product, 2021-2034
  • Table 17: Asia Pacific Bio-Decontamination Market Revenue (USD million) Forecast, By Agent, 2021-2034
  • Table 18: Asia Pacific Bio-Decontamination Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 19: Asia Pacific Bio-Decontamination Market Revenue (USD million) Forecast, By End User, 2021-2034
  • Table 20: Asia Pacific Bio-Decontamination Market Revenue (USD million) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 21: Rest of the World Bio-Decontamination Market Revenue (USD million) Forecast, By Product, 2021-2034
  • Table 22: Rest of the World Bio-Decontamination Market Revenue (USD million) Forecast, By Agent, 2021-2034
  • Table 23: Rest of the World Bio-Decontamination Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 24: Rest of the World Bio-Decontamination Market Revenue (USD million) Forecast, By End User, 2021-2034

List of Figures

  • Figure 01: Global Bio-Decontamination Market Value Share (%), By Product, 2025 & 2034
  • Figure 02: Global Bio-Decontamination Market Value Share (%), By Agent, 2025 & 2034
  • Figure 03: Global Bio-Decontamination Market Value Share (%), By Type, 2025 & 2034
  • Figure 04: Global Bio-Decontamination Market Value Share (%), By End User, 2025 & 2034
  • Figure 05: Global Bio-Decontamination Market Value Share (%), By Region, 2025 & 2034
  • Figure 06: North America Bio-Decontamination Market Value (USD million), By Product, 2025 & 2034
  • Figure 07: North America Bio-Decontamination Market Value Share (%), By Product, 2025
  • Figure 08: North America Bio-Decontamination Market Value (USD million), By Agent, 2025 & 2034
  • Figure 09: North America Bio-Decontamination Market Value Share (%), By Agent, 2025
  • Figure 10: North America Bio-Decontamination Market Value (USD million), By Type, 2025 & 2034
  • Figure 11: North America Bio-Decontamination Market Value Share (%), By Type, 2025
  • Figure 12: North America Bio-Decontamination Market Value (USD million), By End User, 2025 & 2034
  • Figure 13: North America Bio-Decontamination Market Value Share (%), By End User, 2025
  • Figure 14: North America Bio-Decontamination Market Value (USD million), By Country, 2025 & 2034
  • Figure 15: North America Bio-Decontamination Market Value Share (%), By Country, 2025
  • Figure 16: Europe Bio-Decontamination Market Value (USD million), By Product, 2025 & 2034
  • Figure 17: Europe Bio-Decontamination Market Value Share (%), By Product, 2025
  • Figure 18: Europe Bio-Decontamination Market Value (USD million), By Agent, 2025 & 2034
  • Figure 19: Europe Bio-Decontamination Market Value Share (%), By Agent, 2025
  • Figure 20: Europe Bio-Decontamination Market Value (USD million), By Type, 2025 & 2034
  • Figure 21: Europe Bio-Decontamination Market Value Share (%), By Type, 2025
  • Figure 22: Europe Bio-Decontamination Market Value (USD million), By End User, 2025 & 2034
  • Figure 23: Europe Bio-Decontamination Market Value Share (%), By End User, 2025
  • Figure 24: Europe Bio-Decontamination Market Value (USD million), By Country/Sub-Region, 2025 & 2034
  • Figure 25: Europe Bio-Decontamination Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 26: Asia Pacific Bio-Decontamination Market Value (USD million), By Product, 2025 & 2034
  • Figure 27: Asia Pacific Bio-Decontamination Market Value Share (%), By Product, 2025
  • Figure 28: Asia Pacific Bio-Decontamination Market Value (USD million), By Agent, 2025 & 2034
  • Figure 29: Asia Pacific Bio-Decontamination Market Value Share (%), By Agent, 2025
  • Figure 30: Asia Pacific Bio-Decontamination Market Value (USD million), By Type, 2025 & 2034
  • Figure 31: Asia Pacific Bio-Decontamination Market Value Share (%), By Type, 2025
  • Figure 32: Asia Pacific Bio-Decontamination Market Value (USD million), By End User, 2025 & 2034
  • Figure 33: Asia Pacific Bio-Decontamination Market Value Share (%), By End User, 2025
  • Figure 34: Asia Pacific Bio-Decontamination Market Value (USD million), By Country/ Sub-Region, 2025 & 2034
  • Figure 35: Asia Pacific Bio-Decontamination Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 36: Rest of the World Bio-Decontamination Market Value (USD million), By Product, 2025 & 2034
  • Figure 37: Rest of the World Bio-Decontamination Market Value Share (%), By Product, 2025
  • Figure 38: Rest of the World Bio-Decontamination Market Value (USD million), By Agent, 2025 & 2034
  • Figure 39: Rest of the World Bio-Decontamination Market Value Share (%), By Agent, 2025
  • Figure 40: Rest of the World Bio-Decontamination Market Value (USD million), By Type, 2025 & 2034
  • Figure 41: Rest of the World Bio-Decontamination Market Value Share (%), By Type, 2025
  • Figure 42: Rest of the World Bio-Decontamination Market Value (USD million), By End User, 2025 & 2034
  • Figure 43: Rest of the World Bio-Decontamination Market Value Share (%), By End User, 2025
  • Figure 44: Global Bio-Decontamination Market Share (%), 2025